INT-04 DRUG INTERFERENCE TEST

Manufacturers and clinical laboratories are doing a reasonably good job assessing endogenous interferents that may alter lab test results. The next big hurdle is the assessment of interference from common drugs. There are literally hundreds of drugs in clinical use, both prescription and over-the-counter, which can vary widely in their blood and urine concentrations and which can introduce errors in laboratory testing. Which are the most important to test? An expert panel was convened to make specific recommendations concerning the drugs and concentrations that should be assessed when validating laboratory tests.

Preparing concentrated drug solutions for interference testing has been labor intensive and expensive ̶ until now. Sun Diagnostics now offers ASSURANCE™ DRUG Interference Test Kit for Laboratory Use as part of interference testing procedures. Interferents available include: ACETAMINOPHEN, N-ACETYLCYSTEINE, ACETYLSALICYLIC ACID, AMPICILLIN SODIUM, CEFOXITIN SODIUM, CYCLOSPORINE, DOXYCYCLINE HCL, HEPARIN, IBUPROFEN, LEVODOPA, METHYLDOPA, METRONIDAZOLE, PHENYLBUTAZONE, RIFAMPICIN, and THEOPHYLLINE. Components may be purchased individually, in customer-defined combinations, or as INT-04 (one vial of each component).

Drug components and concentrations are based on recommendations by the expert panel1 and the Clinical Laboratory Standards Institute (CLSI).2 The concentrations are 20 times the recommended test concentrations, allowing a 1:20 dilution with serum/urine pool.

SunDiag_2_Product-2box-cropped

Interferents and Typical Values Table:

ASSURANCE Drug Interference Test Kit
PN: INT-04 Price: $1100
Includes: One vial of each component, packaged in 2 kit boxes
Individual Interferents $100/vial
Interferent(1 mL vial) ASSURANCE
Concentration*
Component PN
ACETAMINOPHEN 312 mg/dL INT-04ACM
AMPICILLIN NA 150 mg/dL INT-04AMP
ACETYLSALICYLIC ACID** 60 mg/dL INT-04ASA
DOXYCYCLINE HCL 36 mg/dL INT-04DOX
CEFOXITIN NA 13,200 mg/dL INT-04CEF
HEPARIN 66,000 U/L INT-04HEP
CYCLOSPORINE** 3.6 mg/dL INT-04CYC
LEVODOPA 15 mg/dL INT-04LEV
IBUPROFEN** 438 mg/dL INT-04IBU
METHYLDOPA 45 mg/dL INT-04MED
PHENYLBUTAZONE** 642 mg/dL INT-04PHE
METRONIDAZOLE 246 mg/dL INT-04MET
RIFAMPICIN** 96 mg/dL INT-04RIF
THEOPHYLLINE 120 mg/dL INT-04THE
ACETYLCYSTEINE 300 mg/dL INT-04ACC
Ethanol For control pools for analytes marked ** INT-04E

References:

1 Sonntag O, Scholer A. Drug interference in clinical chemistry: recommendations of drugs and their concentrations to be used in drug interference studies. Ann Clin Biochem 2001; 38:376-385.
2 Clinical and Laboratory Standards Institute (CLSI). Interference Testing in Clinical Chemistry; Approved Guideline ̶ Second Edition. CLSI document EP7-A2 (ISBN 1-56238-584-4). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2005.

Limitations:

  • INT-04 should not be used past the expiration date listed on the kit box. Refer to Interferent vials for expiration of individually purchased components or custom kit configurations.
  • If there is evidence of microbial contamination discard the vial.
  • This product is not intended for use as a control, standard or calibrator.
  • Information gathered from experiments performed using ASSURANCE™ Interference Test Kits should not be used to adjust patient results. Confirm results with an alternate method when necessary.

Items for Download: